Salarius Pharmaceuticals, Inc. (SLRX)
0.8098
-0.06
(-6.71%)
USD |
NASDAQ |
Dec 11, 16:00
0.8101
0.00 (0.00%)
After-Hours: 06:16
Salarius Pharmaceuticals EPS Diluted (Quarterly): -1.814 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Aptevo Therapeutics, Inc. | -2.230 |
| Outset Medical, Inc. | -1.003 |
| Vor Biopharma, Inc. | -121.63 |
| Humacyte, Inc. | -0.1106 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.8735M |
| Total Expenses (Quarterly) | 0.8735M |
| Enterprise Value | -4.397M |
| Earnings Yield | -3.07K% |
| Normalized Earnings Yield | -3068.18 |